Investigating AMD-Like Disease in Animal Models
About the Research Project
Program
Award Type
New Investigator Grant
Award Amount
$450,000
Active Dates
July 01, 2024 - June 30, 2027
Grant ID
M2024011N
Goals
This project will use unique small animal models to investigate mechanisms of retinal degeneration associated with age-related macular degeneration and inform future treatment development.
Summary
Age-related macular degeneration (AMD) research has been hindered by the lack of models that encapsulate its complex features. An important feature of AMD is retinal deposits of fat and protein debris, but researchers know little about where they come from and how they may confer an increased risk of severe AMD in the people who have them. To address this, researchers have created two animal models that develop two different types of AMD-associated retinal deposits. This work will provide significant insight into the deposit origin, treatments, and causative relationship to severe AMD.
Unique and Innovative
This proposal introduces two new animal models of AMD. The identification and development of new models is extremely important because the retina is complex and has close relationships with support cells like the retinal pigment epithelium and Muller glia that do not exist in cell culture models. Animal models that develop hallmarks of AMD allow us to build a foundation of knowledge that will lead to many breakthroughs in our understanding of the cellular mechanisms underlying AMD by tracking disease progression and developing new therapeutics through genetic modification and pharmaceuticals.
Foreseeable Benefits
The characterization of these new animal models will help us to build a foundation of knowledge upon which we can build upon to learn more about the cellular processes that underlie AMD. They will help us to ask questions about: changes that occur in early AMD that are not detectable in the clinic, potential biomarkers of AMD and their relationships with severe disease progression, and new cellular pathways that we can exploit to develop new and effective treatments for AMD.
Grants
Related Grants
Macular Degeneration Research
Understanding Early Molecular Events in Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Sandeep Moothedath Subrahmanian, PhD
Understanding Early Molecular Events in Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Sandeep Moothedath Subrahmanian, PhD
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Macular Degeneration Research
Identifying Signals That Draw Immune Cells to Damaged Tissues in Age-Related Macular Degeneration
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Kelly Mulfaul, PhD
Identifying Signals That Draw Immune Cells to Damaged Tissues in Age-Related Macular Degeneration
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Kelly Mulfaul, PhD